Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy.
Mol Ther Oncolytics. 2023 Aug 5;30:117-131. doi: 10.1016/j.omto.2023.08.001. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37654972
Free PMC article.
Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma.
Krabbe T, Marek J, Groll T, Steiger K, Schmid RM, Krackhardt AM, Altomonte J.
Krabbe T, et al. Among authors: marek j.
Cancers (Basel). 2021 Mar 2;13(5):1044. doi: 10.3390/cancers13051044.
Cancers (Basel). 2021.
PMID: 33801359
Free PMC article.
Item in Clipboard
Cite
Cite